IMED's Other Investors

IMED raised a round of funding on , .

IMED AB develops human monoclonal antibodies (MABs) that can induce or block natural cell death (apoptosis). There are many medical uses for these antibodies including HIV, cancer and transplantation.…

Articles about IMED's Other Investors: